制药

zhì yào
  • pharmacy
制药制药
制药[zhì yào]
  1. X射线衍射分析技术在新药及制药研究中的应用进展

    The application progress of X-ray diffraction analysis technique in new drug and pharmacy research

  2. 制药企业ERP系统的研究和设计

    The Study and Design of ERP System for Pharmacy Production Enterprise

  3. 法国的一家制药公司陷入资金周转问题,面临清算的危机。

    A French-based pharmaceuticals company ran into cash-flow problems and faced liquidation .

  4. 这种由美国制药公司研制开发的激素可望不久在美国获准使用。

    The hormone , developed by US drug companies , is expected to be cleared for use in the US soon .

  5. 由于我们限制医疗补助金,制药公司获得了数千亿美元。

    Drug companies have been given hundreds of billions of dollars as we limit Medicaid benefits .

  6. “它为制药行业松绑,使他们能够开始治疗衰老这种疾病,而不仅仅是治疗其种种副作用,”他说。

    " It unties the hands of the pharmaceuticalindustry so that they can begin treating the disease and not just the side effects , " he said .

  7. 四川制药企业科伦药业董事长刘革新

    Liu Gexin , chairman of Kelun group , a pharmaceutical enterprise in Sichuan province

  8. 中小制药企业的ERP研究与开发

    The Research and developing of ERP in small and mediocre medical enterprises

  9. HPLC电化学检测法测定制药厂废水中硫脲和硫

    Determination of Thiourea and Sulfide in Wastewater from Pharmaceutical Factory by HPLC-Electrochemical Detection

  10. 制药行业柔性ERP系统的研究与实现

    The Pharmaceutical Industry Flexible ERP System Research and Implementation

  11. PACT法去除维生素B1制药废水中有机物的试验研究

    Study on PACT-process for removal of organic substance in pharmaceutical wastewater of vitamin B_1

  12. 制药厂污水处理中DCS控制系统的应用

    The Application of DCS Control System in Sewage Treatment at Pharmaceutical Factory

  13. D-对羟基苯甘氨酸制药废水COD高,成分复杂。

    D p hydroxyphenyl glycine wastewater has high concentration of COD and various components .

  14. 基于GMP中小制药企业ERP生产管理系统设计

    Design ERP production management system of small and medium-sized pharmacy enterprise based on GMP

  15. 首次采用陶瓷NF膜处理了青霉素制药污水。

    In this study , penicillin pharmaceutical wastewater was treated by ceramic NF membrane firstly .

  16. 制药企业GMP改造中有关操作平台的设计问题

    Design of Operating Platform in GMP Reform of Pharmaceutical Enterprise

  17. Fenton及类Fenton试剂深度处理制药废水的效能研究

    A Effectiveness Research on Pharmaceutical Wastewater Advanced Treatment by Fenton and Fenton-Like Process

  18. 中小型制药企业如何完成GMP认证

    How the Minor Pharmaceutical Enterprises to Finish GMP Certification

  19. 介绍SBR法在制药废水中的应用及工艺流程。

    In this paper , the application and process of SBR treatment for pharmaceutical wastewater is introduced .

  20. 生物制药在位清洗CIP系统配置综述

    Summary of Onsite Cleaning CIP System Disposition in Biological Medicine Production

  21. 制药废液中回收乙腈与DMF

    Recovery of Methyl Cyanide and DMF from Pharmaceutical Effluent

  22. 同时集团正在按GMP要求改造另外一个制药工厂。

    Meanwhile , the corporation is revamping another pharmaceutical plant according to GMP requirements .

  23. 探讨了炔诺孕酮避孕药(18甲,NG)制药工人在长期接触NG药尘的生产环境中对生殖健康的影响。

    We study the effect on reproductive health of workers exposed to NG dust for a long time .

  24. 随着加入WTO,我国医药管理体制逐渐与国际接轨,制药行业对内对外全面放开。

    With the entry to WTO , management systems of medicine of our country are more and more near to the international . The medicine industry unlocked to nation and world .

  25. 制药行业国内CRO的战略管理研究

    A Study on Strategic Management of Chinese CROs in Pharmaceutical Industry

  26. 与此同时,总部位于北京的制药商百济神州(BeiGene)正在与德国制药商默克(Merck)合作开发癌症药物。

    Beijing-based BeiGene , meanwhile , is developing cancer drugs with Merck of Germany .

  27. TY医药公司是一家集研发、生产和销售为一体的新兴、科技型民营制药企业。

    TY Drug Company is a private enterprise that researches , produces and sells medicines .

  28. 分析了如何利用优势,避免威胁(ST)即华北制药集团应开发新的细分市场。

    Analysis of how to make use of advantages and avoid the threat ( ST ) is the North China Pharmaceutical Group should be the development of new market segments .

  29. 在通过GMP认证之后,如何不断地完善和改进既有的质量管理体系是目前制药企业普遍面临的重要问题之一。

    How to improve the proposed quality management system after GMP certification is one of the most important questions the pharmaceutical manufacturers facing .

  30. OEM是在国际市场十分流行并行之有效的生产方式,但在生物制药企业中还不多见。

    OEM was a popular and effective production mode in the international market , but it was still rare in the biological pharmacy enterprises .